NR3C2 and Skin ulcer: ,69 REDD1 has been identified as one of the major drivers of GCs-induced skin atrophy70,71 and, interestingly, we showed that MR antagonists efficiently promoted the healing of GCs-induced skin ulcers,72 potentially linking REDD1 with the MR pathway activation in the skin.